Abeta42 neurotoxicity in primary co-cultures: effect of apoE isoform and Abeta conformation.
about
The generation and function of soluble apoE receptors in the CNSApolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapyTDP-43: a new player on the AD field?Successful therapies for Alzheimer's disease: why so many in animal models and none in humans?Reelin and apoE actions on signal transduction, synaptic function and memory formationFingolimod phosphate attenuates oligomeric amyloid β-induced neurotoxicity via increased brain-derived neurotrophic factor expression in neuronsMicroglia activated with the toll-like receptor 9 ligand CpG attenuate oligomeric amyloid {beta} neurotoxicity in in vitro and in vivo models of Alzheimer's disease.Cognitive effects of cell-derived and synthetically derived Aβ oligomers.ApoE4 induces Aβ42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice.Apolipoprotein E isoform-specific effects on lipoprotein receptor processing.Preparation of fluorescently-labeled amyloid-beta peptide assemblies: the effect of fluorophore conjugation on structure and functionEvidence of altered posteromedial cortical FMRI activity in subjects at risk for Alzheimer diseaseMicroglia activation mediates fibrillar amyloid-β toxicity in the aged primate cortex.In vivo and in vitro effects of an apolipoprotein e mimetic peptide on amyloid-β pathologyMass spectrometry-based protein footprinting characterizes the structures of oligomeric apolipoprotein E2, E3, and E4.APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice.Simultaneous analysis of dendritic spine density, morphology and excitatory glutamate receptors during neuron maturation in vitro by quantitative immunocytochemistryAPOE4-specific changes in Aβ accumulation in a new transgenic mouse model of Alzheimer disease.Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities.Arabidopsis thaliana extracts optimized for polyphenols production as potential therapeutics for the APOE-modulated neuroinflammation characteristic of Alzheimer's disease in vitroPreparing synthetic Aβ in different aggregation states.Haptoglobin modulates beta-amyloid uptake by U-87 MG astrocyte cell line.Apolipoprotein E-mediated Modulation of ADAM10 in Alzheimer's Disease.Endocytic pathways mediating oligomeric Abeta42 neurotoxicity.Involvement of the Apoer2 and Lrp1 receptors in mediating the pathological effects of ApoE4 in vivo.Systemic treatment with liver X receptor agonists raises apolipoprotein E, cholesterol, and amyloid-β peptides in the cerebral spinal fluid of rats.Apolipoprotein e: essential catalyst of the Alzheimer amyloid cascade.Amyloid-β42 alters apolipoprotein E solubility in brains of mice with five familial AD mutations.Cerebrospinal Fluid Proteins as Regulators of Beta-amyloid Aggregation and Toxicity.Soluble Aβ1-42 increases the heterogeneity in synaptic vesicle pool size among synapses by suppressing intersynaptic vesicle sharing.The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade.
P2860
Q21202840-130BD0AB-723E-45C9-BAEC-AC302FE73DF5Q24604376-AA7C0979-2D6E-42FB-B514-7E14FDE29B54Q26823723-6E0D473A-5FF6-4933-9009-65CDEEBB68E4Q26859305-550F854E-7EDE-4940-BF20-2A8B5289A58DQ28254650-268D1AE1-4056-42E5-8ACE-6229C6FE3907Q28486184-B4DBEEB4-7662-4944-9635-3C08BE782428Q30491484-51A34228-8BBA-48C5-BE9A-FC8FC132A322Q30495253-2630296C-F4DA-40D3-B1E7-00A6395AE634Q30539979-28D70C85-2ED1-4738-AA29-8BCC1F7CA970Q33112703-94B59935-1B29-4ADD-8F4B-0C6C14352F3EQ33682529-D0944904-7C1F-4200-BA2A-82EDD3CA5B5FQ33721909-010CE86C-2506-468E-B13A-7D693A9C7A1CQ33926543-62BB88EE-7BF3-4B7B-BE6E-DCA29DB8CD88Q33995580-0A77AE56-37F8-44B3-AF6A-F2B0D63F55EBQ35226230-8E904DD2-B39E-4BB6-B576-CDD740D21A08Q35337169-9E20313C-0CC1-475D-92F1-09E37153D959Q36007872-900C18D7-F9AE-4DA3-8485-F63E7F7330D2Q36451896-61A8F442-5DB3-49F8-B7B6-7DAE52E5B3D8Q37060457-410B2CA5-20CB-4DB8-B79B-494A4C8DD95BQ37073034-5A483152-EE67-4544-A42C-E1207FD2ACCFQ37119634-DEB1CF1F-9A06-4E45-948A-9F8D7290406AQ38939828-2D9AF8CB-E2E0-4DFC-8252-56457A37D7F3Q38977248-E638DE17-BEAD-46DC-A9E5-4F8695EFDB0CQ40893495-48C4ECCF-980E-45CB-8ECE-821E4511EBD9Q40966227-C3DBAF64-3C11-4470-B9ED-E038B6E4C69DQ41702367-D503D585-1C7B-4FC4-AE87-6FBC5D8F2CFDQ42247507-5F7CC20E-5C1C-419A-B67B-745E01A06F59Q42651770-B20B5F4D-4C90-4701-926F-510C8E3D2F06Q47356578-88923E43-4FEB-4E0F-BDE5-B7C5C4394EF3Q49795603-DA0C7CBB-3CB5-4B21-9007-CC12DEB5EDEEQ54977832-B704A39B-D75A-4C00-8CB9-6004906254DF
P2860
Abeta42 neurotoxicity in primary co-cultures: effect of apoE isoform and Abeta conformation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 July 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Abeta42 neurotoxicity in prima ...... soform and Abeta conformation.
@en
Abeta42 neurotoxicity in prima ...... soform and Abeta conformation.
@nl
type
label
Abeta42 neurotoxicity in prima ...... soform and Abeta conformation.
@en
Abeta42 neurotoxicity in prima ...... soform and Abeta conformation.
@nl
prefLabel
Abeta42 neurotoxicity in prima ...... soform and Abeta conformation.
@en
Abeta42 neurotoxicity in prima ...... soform and Abeta conformation.
@nl
P2093
P2860
P1476
Abeta42 neurotoxicity in prima ...... soform and Abeta conformation.
@en
P2093
Arlene M Manelli
Lindsey C Bulfinch
Mary Jo LaDu
Patrick M Sullivan
P2860
P304
P356
10.1016/J.NEUROBIOLAGING.2006.05.024
P577
2006-07-11T00:00:00Z